U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422701) titled 'Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation' on July 13, 2025.
Brief Summary: Portal vein thrombosis (PVT) is a blood-clot complication that occurs in some people with liver cirrhosis and can worsen bleeding, ascites, encephalopathy and survival. However, doctors still lack reliable tools to predict who will develop PVT, how much it really shortens life, and whether anticoagulation (blood-thinner) treatment clearly improves outcomes and is safe.This multicentre, bidirectional cohort study will follow about 2,500 adults with cirrhosis cared for at seven major hospitals in China. The team will first re...